AR243877A1 - Procedimiento para la preparacion de derivados de 8,13-epoxi-9alfa-hidroxi-1alfa lad-14-en-11-ona e intermediarios para uso en dicho procedimiento. - Google Patents

Procedimiento para la preparacion de derivados de 8,13-epoxi-9alfa-hidroxi-1alfa lad-14-en-11-ona e intermediarios para uso en dicho procedimiento.

Info

Publication number
AR243877A1
AR243877A1 AR85302563A AR30256385A AR243877A1 AR 243877 A1 AR243877 A1 AR 243877A1 AR 85302563 A AR85302563 A AR 85302563A AR 30256385 A AR30256385 A AR 30256385A AR 243877 A1 AR243877 A1 AR 243877A1
Authority
AR
Argentina
Prior art keywords
aminoacyllabdanes
medicaments
intermediates
preparation
Prior art date
Application number
AR85302563A
Other languages
English (en)
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Application granted granted Critical
Publication of AR243877A1 publication Critical patent/AR243877A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/92Naphthopyrans; Hydrogenated naphthopyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D497/00Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AR85302563A 1984-12-14 1985-12-12 Procedimiento para la preparacion de derivados de 8,13-epoxi-9alfa-hidroxi-1alfa lad-14-en-11-ona e intermediarios para uso en dicho procedimiento. AR243877A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68177984A 1984-12-14 1984-12-14

Publications (1)

Publication Number Publication Date
AR243877A1 true AR243877A1 (es) 1993-09-30

Family

ID=24736768

Family Applications (1)

Application Number Title Priority Date Filing Date
AR85302563A AR243877A1 (es) 1984-12-14 1985-12-12 Procedimiento para la preparacion de derivados de 8,13-epoxi-9alfa-hidroxi-1alfa lad-14-en-11-ona e intermediarios para uso en dicho procedimiento.

Country Status (19)

Country Link
EP (1) EP0191166B1 (es)
JP (1) JPS61145178A (es)
KR (1) KR900007625B1 (es)
AR (1) AR243877A1 (es)
AT (1) ATE60767T1 (es)
AU (2) AU577912B2 (es)
CA (1) CA1307529C (es)
DE (1) DE3581725D1 (es)
DK (1) DK167218B1 (es)
ES (1) ES8703460A1 (es)
FI (1) FI87208C (es)
GR (1) GR852981B (es)
HU (1) HU201043B (es)
IE (1) IE58698B1 (es)
NO (1) NO171064C (es)
NZ (1) NZ214532A (es)
PH (1) PH24599A (es)
PT (1) PT81659B (es)
ZA (1) ZA859556B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0193132B1 (en) * 1985-03-01 1991-04-17 Hoechst-Roussel Pharmaceuticals Incorporated Labdan-derivatives, a process for their preparation and their use as medicaments
IN163242B (es) * 1985-05-03 1988-08-27 Hoechst India
JPS6310783A (ja) * 1985-11-15 1988-01-18 Nippon Kayaku Co Ltd 新規フオルスコリン誘導体
AU591196B2 (en) * 1985-11-15 1989-11-30 Nippon Kayaku Kabushiki Kaisha Novel forskolin derivatives
US4734513A (en) * 1986-03-31 1988-03-29 Hoechst-Roussel Pharmaceuticals Inc. Method of synthesizing forskolin from 9-deoxyforskolin
US4740522A (en) * 1986-08-28 1988-04-26 Hoechst-Roussel Pharmaceuticals Inc. Oxolabdanes useful as pharmaceuticals for reducing intraocular pressure
US5247097A (en) * 1986-08-28 1993-09-21 Hoechst-Roussel Pharmaceuticals Incorporated Oxolabdanes
US5646175A (en) * 1987-12-28 1997-07-08 Hoechst Marion Roussel, Inc. Carbamoyloxylabdane compounds
US4920146A (en) * 1986-12-29 1990-04-24 Hoechst Roussel Pharmaceuticals Inc. Carbamoyloxylabdane compounds useful in reducing intraocular pressure
NZ223051A (en) * 1986-12-29 1990-06-26 Hoechst Roussel Pharma Carbamoyloxylabdane derivatives and pharmaceutical compositions
US5302730A (en) * 1987-06-29 1994-04-12 Nippon Kayaku Kk Process for the preparation of 6,7-diacyl-7-deacetylforskolin derivatives
US4916204A (en) * 1987-07-31 1990-04-10 Massachusetts Institute Of Technology Pure polyanhydride from dicarboxylic acid and coupling agent
US5846992A (en) * 1987-10-08 1998-12-08 Hoechst Marion Roussel, Inc. Synergistic intraocular pressure lowering combinations
US4902696A (en) * 1987-10-08 1990-02-20 Hoechst-Roussel Pharmaceuticals, Inc. Synergistic intraocular pressure lowering combinations
US4883793A (en) * 1988-05-09 1989-11-28 Hoechst-Roussel Pharmaceuticals Inc. Hydrazinocarbonyloxylabdanes for treating cardiac failure
US5051132A (en) * 1989-06-15 1991-09-24 Nippon Kayaku Kabushiki Kaisha Lyophilized preparation of 6-(3-dimethylaminopropionyl)forskolin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2654796A1 (de) * 1976-12-03 1978-06-08 Hoechst Ag Polyoxygenierte labdan-derivate
IL59004A0 (en) * 1978-12-30 1980-03-31 Beecham Group Ltd Substituted benzamides their preparation and pharmaceutical compositions containing them
EP0193132B1 (en) * 1985-03-01 1991-04-17 Hoechst-Roussel Pharmaceuticals Incorporated Labdan-derivatives, a process for their preparation and their use as medicaments

Also Published As

Publication number Publication date
KR900007625B1 (ko) 1990-10-17
DK167218B1 (da) 1993-09-20
DE3581725D1 (de) 1991-03-14
PT81659B (pt) 1988-04-21
NZ214532A (en) 1989-05-29
PT81659A (en) 1986-01-01
FI854919A (fi) 1986-06-15
IE58698B1 (en) 1993-11-03
EP0191166A3 (en) 1988-03-02
ES549860A0 (es) 1987-02-16
FI87208B (fi) 1992-08-31
FI87208C (fi) 1992-12-10
EP0191166A2 (en) 1986-08-20
JPS61145178A (ja) 1986-07-02
ATE60767T1 (de) 1991-02-15
NO171064C (no) 1993-01-20
CA1307529C (en) 1992-09-15
ZA859556B (en) 1986-08-27
HUT40636A (en) 1987-01-28
NO171064B (no) 1992-10-12
AU3813289A (en) 1989-10-26
AU620421B2 (en) 1992-02-20
EP0191166B1 (en) 1991-02-06
ES8703460A1 (es) 1987-02-16
AU5131685A (en) 1986-07-17
NO855026L (no) 1986-06-16
HU201043B (en) 1990-09-28
IE853160L (en) 1986-06-14
PH24599A (en) 1990-08-17
FI854919A0 (fi) 1985-12-12
DK578585A (da) 1986-06-15
DK578585D0 (da) 1985-12-13
KR860004915A (ko) 1986-07-16
AU577912B2 (en) 1988-10-06
GR852981B (es) 1986-04-08

Similar Documents

Publication Publication Date Title
EP0161632A3 (en) Pyrrolo-benzimidazoles, process for their preparation, medicaments containing them and intermediates
AU589141B2 (en) 9-amino-1,2,3,4- tetrahydroacridin - 1- OL and related compounds, a process for their preparation and their use as medicaments
ZA858163B (en) 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds,a process for their preparation and their use as medicaments
AU6824090A (en) Intermediates for substituted 9-amino-tetrahydro-acridines, a process for their preparation and their use as medicaments
PT81629B (en) 1,4-dihydropyridines a process and intermediates for their preparation and their use as medicaments
AR243877A1 (es) Procedimiento para la preparacion de derivados de 8,13-epoxi-9alfa-hidroxi-1alfa lad-14-en-11-ona e intermediarios para uso en dicho procedimiento.
ZA868065B (en) Antihypertensive thieno-isoxazoles and-pyrazoles,a process and intermediates for their preparation and their use as medicaments
IL83152A0 (en) 7-acyloxy-6-aminoacyloxypolyoxylabdanes,a process for their preparation,and their use as medicaments
ZA854287B (en) Dialkoxypyridines,process for their preparation,their use and medicaments containing them
DE3566114D1 (en) Spergualin-related compounds having a phenylene group, a process for their preparation and their use as medicaments
EP0424848A3 (en) Aminopyridinylaminophenols and related compounds, a process and intermediates for their preparation and their use as medicaments
ZA879694B (en) Novel carbamoyloxylabdanes,intermediates and a process for the preparation thereof and their use as medicaments
ZA856775B (en) Histargin-related compounds,a process for their preparation and their use as medicaments
PT80276A (en) Substituted 1-aminoalkylamino-4-aryloxypiperidines a process for their preparation intermediates thereof and their use as medicaments
ZA882811B (en) Fused heteroalkylene quinolinamines,a process and intermediates for their preparation and their use as medicaments
PT82427A (en) Ethanobenzazepines a process and intermediates for their preparation and their use as medicaments
ZA855584B (en) New combination product,a process for its preparation and its use as a medicament
IL66367A0 (en) Oxothienobenzoxepins,a method for their preparation and their use as medicaments
ZA866444B (en) Spergualin-related compounds,a process for their preparation and their use as medicaments
ZA88409B (en) 3-methylenespiro/benzofuranpiperidines/,intermediates and a process for the preparation thereof,and their use as medicaments
ZA9010327B (en) Thienobenzoxepin-and napphthothiophene-derivatives,a process and intermediates for their preparation and their use as medicaments
ZA887087B (en) 2,6-methanopyrrolo-3-benzazocines,a process and intermediates for their preparation and their use as medicaments
AU6823990A (en) Intermediates for substituted 9-amino-tetrahydro-acridines, a process for their preparation and their use as medicaments
ZA867188B (en) Alkenylazoles,a process for their preparation and their use
ZA872745B (en) 1-hydroxy-2-pyridones,a process for their preparation,and medicaments which contain them,and intermediates formed in the preparation of the 1-hydroxy-2-pyridones